| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Computational Biology | 24 | 2025 | 862 | 2.990 |
Why?
|
| Mutation, Missense | 11 | 2025 | 919 | 1.630 |
Why?
|
| Genetic Variation | 11 | 2026 | 1559 | 1.300 |
Why?
|
| Genetic Fitness | 6 | 2024 | 34 | 1.000 |
Why?
|
| Tumor Suppressor Protein p53 | 8 | 2024 | 722 | 0.800 |
Why?
|
| Amino Acid Substitution | 6 | 2025 | 405 | 0.780 |
Why?
|
| Polymorphism, Single Nucleotide | 10 | 2026 | 2833 | 0.650 |
Why?
|
| Phenotype | 16 | 2025 | 4497 | 0.650 |
Why?
|
| Evolution, Molecular | 5 | 2019 | 644 | 0.600 |
Why?
|
| Mutation | 20 | 2025 | 6099 | 0.580 |
Why?
|
| Genome, Human | 3 | 2024 | 1321 | 0.550 |
Why?
|
| Databases, Genetic | 8 | 2025 | 504 | 0.540 |
Why?
|
| Genetic Testing | 3 | 2025 | 1106 | 0.500 |
Why?
|
| Sequence Analysis, DNA | 2 | 2019 | 1692 | 0.500 |
Why?
|
| Germ-Line Mutation | 2 | 2017 | 373 | 0.500 |
Why?
|
| Intellectual Disability | 4 | 2025 | 1089 | 0.440 |
Why?
|
| Genetic Predisposition to Disease | 11 | 2026 | 3436 | 0.420 |
Why?
|
| Genotype | 4 | 2022 | 2595 | 0.410 |
Why?
|
| Open Reading Frames | 1 | 2014 | 198 | 0.410 |
Why?
|
| Genetics, Medical | 1 | 2014 | 119 | 0.400 |
Why?
|
| Exome | 3 | 2024 | 1061 | 0.400 |
Why?
|
| Neurodevelopmental Disorders | 3 | 2025 | 629 | 0.380 |
Why?
|
| Humans | 63 | 2026 | 131163 | 0.350 |
Why?
|
| Calmodulin | 2 | 2024 | 212 | 0.350 |
Why?
|
| Models, Genetic | 7 | 2022 | 749 | 0.340 |
Why?
|
| ROC Curve | 3 | 2025 | 613 | 0.330 |
Why?
|
| Autism Spectrum Disorder | 3 | 2021 | 450 | 0.330 |
Why?
|
| Breast Neoplasms | 5 | 2026 | 2602 | 0.330 |
Why?
|
| Proteins | 4 | 2014 | 1006 | 0.320 |
Why?
|
| Mitochondrial Proteins | 2 | 2025 | 283 | 0.320 |
Why?
|
| Mitochondrial Diseases | 2 | 2025 | 158 | 0.320 |
Why?
|
| Head and Neck Neoplasms | 5 | 2023 | 638 | 0.310 |
Why?
|
| Escherichia coli | 3 | 2023 | 991 | 0.310 |
Why?
|
| Neoplasms | 3 | 2022 | 3016 | 0.270 |
Why?
|
| Chemistry, Physical | 2 | 2007 | 25 | 0.260 |
Why?
|
| Gene Frequency | 3 | 2025 | 729 | 0.260 |
Why?
|
| Algorithms | 7 | 2024 | 1680 | 0.260 |
Why?
|
| Models, Molecular | 8 | 2026 | 1064 | 0.240 |
Why?
|
| Biophysics | 1 | 2006 | 47 | 0.240 |
Why?
|
| Cell Cycle Proteins | 3 | 2019 | 710 | 0.240 |
Why?
|
| Cisplatin | 3 | 2023 | 274 | 0.230 |
Why?
|
| A Kinase Anchor Proteins | 2 | 2018 | 21 | 0.230 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2016 | 750 | 0.230 |
Why?
|
| Cerebroside-Sulfatase | 1 | 2025 | 9 | 0.220 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2025 | 88 | 0.220 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2025 | 107 | 0.210 |
Why?
|
| Ribonucleotides | 1 | 2024 | 31 | 0.210 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2024 | 62 | 0.210 |
Why?
|
| RNA Stability | 1 | 2024 | 77 | 0.210 |
Why?
|
| Hyperparathyroidism | 1 | 2024 | 21 | 0.200 |
Why?
|
| Reproducibility of Results | 3 | 2022 | 2904 | 0.200 |
Why?
|
| DNA Replication | 1 | 2026 | 355 | 0.200 |
Why?
|
| Ovarian Neoplasms | 2 | 2019 | 420 | 0.200 |
Why?
|
| Genetic Association Studies | 3 | 2017 | 819 | 0.200 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2024 | 188 | 0.190 |
Why?
|
| Selection, Genetic | 3 | 2022 | 150 | 0.190 |
Why?
|
| DNA | 2 | 2026 | 1399 | 0.190 |
Why?
|
| Protein Stability | 5 | 2024 | 165 | 0.190 |
Why?
|
| Software | 2 | 2025 | 733 | 0.190 |
Why?
|
| RNA Splicing | 1 | 2024 | 235 | 0.180 |
Why?
|
| Calculi | 1 | 2022 | 12 | 0.180 |
Why?
|
| Phylogeny | 3 | 2021 | 689 | 0.180 |
Why?
|
| Rare Diseases | 1 | 2024 | 210 | 0.170 |
Why?
|
| Mobile Applications | 1 | 2023 | 114 | 0.170 |
Why?
|
| Nucleic Acids | 1 | 2021 | 25 | 0.170 |
Why?
|
| Severe Acute Respiratory Syndrome | 1 | 2021 | 39 | 0.170 |
Why?
|
| Xanthines | 1 | 2021 | 10 | 0.170 |
Why?
|
| Apraxias | 1 | 2021 | 14 | 0.170 |
Why?
|
| Glycoside Hydrolases | 1 | 2021 | 16 | 0.170 |
Why?
|
| Thermodynamics | 3 | 2025 | 147 | 0.170 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2025 | 357 | 0.160 |
Why?
|
| Lung Neoplasms | 2 | 2025 | 1545 | 0.160 |
Why?
|
| DNA-Activated Protein Kinase | 1 | 2020 | 27 | 0.160 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2021 | 125 | 0.150 |
Why?
|
| Acetylglucosaminidase | 1 | 2019 | 10 | 0.150 |
Why?
|
| Cystathionine beta-Synthase | 1 | 2019 | 14 | 0.150 |
Why?
|
| Small Molecule Libraries | 1 | 2021 | 129 | 0.150 |
Why?
|
| Yeasts | 1 | 2019 | 43 | 0.150 |
Why?
|
| Escherichia coli Proteins | 1 | 2022 | 319 | 0.150 |
Why?
|
| Checkpoint Kinase 2 | 1 | 2019 | 37 | 0.150 |
Why?
|
| Iron-Binding Proteins | 1 | 2019 | 25 | 0.150 |
Why?
|
| BRCA2 Protein | 1 | 2019 | 55 | 0.150 |
Why?
|
| Protein Conformation | 6 | 2019 | 732 | 0.150 |
Why?
|
| Antineoplastic Agents | 2 | 2023 | 1826 | 0.150 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2017 | 116 | 0.150 |
Why?
|
| Circular Dichroism | 3 | 2025 | 63 | 0.150 |
Why?
|
| BRCA1 Protein | 1 | 2019 | 78 | 0.150 |
Why?
|
| Computer Simulation | 5 | 2019 | 674 | 0.150 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2022 | 401 | 0.150 |
Why?
|
| Sex Factors | 1 | 2023 | 1356 | 0.150 |
Why?
|
| Autoantigens | 1 | 2019 | 97 | 0.140 |
Why?
|
| Blood Glucose | 1 | 2023 | 1117 | 0.140 |
Why?
|
| Cell Line, Tumor | 7 | 2024 | 3748 | 0.140 |
Why?
|
| Phenylalanine-tRNA Ligase | 1 | 2018 | 3 | 0.140 |
Why?
|
| Methyltransferases | 1 | 2019 | 78 | 0.140 |
Why?
|
| Crystallography, X-Ray | 3 | 2026 | 364 | 0.140 |
Why?
|
| Viral Vaccines | 1 | 2021 | 324 | 0.140 |
Why?
|
| Phosphorylation | 5 | 2025 | 1571 | 0.140 |
Why?
|
| Amino Acyl-tRNA Synthetases | 1 | 2018 | 25 | 0.140 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 12 | 1 | 2018 | 18 | 0.140 |
Why?
|
| Biological Evolution | 2 | 2022 | 222 | 0.140 |
Why?
|
| GTP Phosphohydrolases | 1 | 2019 | 155 | 0.140 |
Why?
|
| Hepatectomy | 1 | 2019 | 131 | 0.140 |
Why?
|
| Sequence Alignment | 1 | 2019 | 582 | 0.140 |
Why?
|
| Enzyme Inhibitors | 1 | 2021 | 573 | 0.140 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 176 | 0.140 |
Why?
|
| Anoctamins | 1 | 2017 | 13 | 0.130 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 4 | 2 | 2018 | 12 | 0.130 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2019 | 252 | 0.130 |
Why?
|
| Mitochondria | 2 | 2025 | 785 | 0.130 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2017 | 5 | 0.130 |
Why?
|
| Pyruvate Kinase | 1 | 2017 | 11 | 0.130 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2023 | 821 | 0.130 |
Why?
|
| Autistic Disorder | 1 | 2021 | 398 | 0.130 |
Why?
|
| Codon | 1 | 2017 | 93 | 0.130 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2018 | 157 | 0.130 |
Why?
|
| Area Under Curve | 1 | 2017 | 304 | 0.120 |
Why?
|
| Job Syndrome | 1 | 2016 | 17 | 0.120 |
Why?
|
| Female | 20 | 2026 | 70963 | 0.120 |
Why?
|
| Schizophrenia | 1 | 2019 | 324 | 0.120 |
Why?
|
| Benchmarking | 1 | 2017 | 137 | 0.120 |
Why?
|
| Precision Medicine | 2 | 2019 | 388 | 0.120 |
Why?
|
| Receptors, Cell Surface | 1 | 2018 | 420 | 0.120 |
Why?
|
| False Positive Reactions | 1 | 2016 | 143 | 0.110 |
Why?
|
| Alzheimer Disease | 1 | 2023 | 878 | 0.110 |
Why?
|
| Antiviral Agents | 1 | 2021 | 807 | 0.110 |
Why?
|
| Osteogenesis Imperfecta | 1 | 2017 | 182 | 0.110 |
Why?
|
| DNA-Binding Proteins | 2 | 2020 | 1939 | 0.110 |
Why?
|
| Tongue Neoplasms | 1 | 2015 | 30 | 0.110 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2014 | 59 | 0.110 |
Why?
|
| STAT3 Transcription Factor | 1 | 2016 | 229 | 0.110 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2018 | 280 | 0.110 |
Why?
|
| Serine Endopeptidases | 2 | 2014 | 197 | 0.100 |
Why?
|
| Imidazoles | 1 | 2015 | 219 | 0.100 |
Why?
|
| Protein Interaction Mapping | 1 | 2014 | 87 | 0.100 |
Why?
|
| Neoplasm Metastasis | 1 | 2016 | 713 | 0.100 |
Why?
|
| Morbidity | 1 | 2014 | 256 | 0.100 |
Why?
|
| Piperazines | 1 | 2015 | 265 | 0.100 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2014 | 219 | 0.100 |
Why?
|
| Genetics, Population | 1 | 2014 | 178 | 0.100 |
Why?
|
| Models, Chemical | 3 | 2011 | 78 | 0.100 |
Why?
|
| Nuclear Proteins | 2 | 2020 | 1211 | 0.100 |
Why?
|
| Colorectal Neoplasms | 1 | 2019 | 621 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2023 | 1459 | 0.090 |
Why?
|
| Protein Domains | 2 | 2026 | 252 | 0.090 |
Why?
|
| Monte Carlo Method | 3 | 2007 | 98 | 0.090 |
Why?
|
| Rec A Recombinases | 1 | 2011 | 27 | 0.090 |
Why?
|
| Desmosterol | 1 | 2011 | 3 | 0.090 |
Why?
|
| Carbamoyl-Phosphate Synthase I Deficiency Disease | 1 | 2011 | 5 | 0.090 |
Why?
|
| Carbamoyl-Phosphate Synthase (Ammonia) | 1 | 2011 | 8 | 0.090 |
Why?
|
| Membrane Proteins | 1 | 2019 | 1590 | 0.090 |
Why?
|
| Polymorphism, Genetic | 1 | 2014 | 776 | 0.090 |
Why?
|
| Lipid Metabolism, Inborn Errors | 1 | 2011 | 30 | 0.080 |
Why?
|
| DNA Mutational Analysis | 2 | 2011 | 775 | 0.080 |
Why?
|
| Hyperammonemia | 1 | 2011 | 59 | 0.080 |
Why?
|
| Mice, Nude | 3 | 2018 | 700 | 0.080 |
Why?
|
| Binding Sites | 3 | 2019 | 1133 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2022 | 2596 | 0.080 |
Why?
|
| DNA Copy Number Variations | 1 | 2015 | 1029 | 0.080 |
Why?
|
| Male | 11 | 2025 | 64957 | 0.080 |
Why?
|
| Ribonucleotide Reductases | 1 | 2009 | 10 | 0.080 |
Why?
|
| Bacterial Proteins | 2 | 2014 | 953 | 0.080 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2014 | 633 | 0.080 |
Why?
|
| Mitochondrial Encephalomyopathies | 1 | 2009 | 27 | 0.070 |
Why?
|
| Gastrointestinal Motility | 1 | 2009 | 65 | 0.070 |
Why?
|
| Apoptosis | 1 | 2015 | 1827 | 0.070 |
Why?
|
| Signal Transduction | 2 | 2018 | 4686 | 0.070 |
Why?
|
| Animals | 9 | 2024 | 33912 | 0.070 |
Why?
|
| Child, Preschool | 5 | 2025 | 15110 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 2019 | 1373 | 0.070 |
Why?
|
| Biomedical Research | 1 | 2014 | 561 | 0.070 |
Why?
|
| Structure-Activity Relationship | 2 | 2021 | 552 | 0.070 |
Why?
|
| Myocardium | 1 | 2013 | 852 | 0.070 |
Why?
|
| Protein Binding | 3 | 2018 | 1652 | 0.070 |
Why?
|
| DNA, Mitochondrial | 1 | 2009 | 233 | 0.070 |
Why?
|
| Machine Learning | 2 | 2025 | 387 | 0.070 |
Why?
|
| Genome-Wide Association Study | 1 | 2014 | 1833 | 0.060 |
Why?
|
| Ions | 1 | 2006 | 25 | 0.060 |
Why?
|
| Hydrogen Bonding | 1 | 2006 | 84 | 0.060 |
Why?
|
| Solvents | 1 | 2006 | 39 | 0.060 |
Why?
|
| Molecular Conformation | 1 | 2006 | 96 | 0.060 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2024 | 399 | 0.060 |
Why?
|
| Scattering, Small Angle | 1 | 2026 | 10 | 0.060 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 2323 | 0.060 |
Why?
|
| Temperature | 1 | 2006 | 291 | 0.060 |
Why?
|
| Gastrointestinal Diseases | 1 | 2009 | 343 | 0.060 |
Why?
|
| Biological Specimen Banks | 1 | 2026 | 72 | 0.060 |
Why?
|
| United Kingdom | 1 | 2026 | 267 | 0.060 |
Why?
|
| Protein Multimerization | 1 | 2026 | 148 | 0.060 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 2121 | 0.050 |
Why?
|
| Adult | 6 | 2025 | 31282 | 0.050 |
Why?
|
| RNA-Binding Motifs | 1 | 2024 | 3 | 0.050 |
Why?
|
| Gene Deletion | 2 | 2018 | 767 | 0.050 |
Why?
|
| Cell Survival | 2 | 2018 | 826 | 0.050 |
Why?
|
| Age of Onset | 1 | 2026 | 592 | 0.050 |
Why?
|
| Middle Aged | 5 | 2026 | 28601 | 0.050 |
Why?
|
| Protein Isoforms | 2 | 2018 | 423 | 0.050 |
Why?
|
| Models, Statistical | 1 | 2006 | 483 | 0.050 |
Why?
|
| Adolescent | 4 | 2025 | 20987 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2018 | 1011 | 0.050 |
Why?
|
| Mutation Rate | 1 | 2023 | 68 | 0.050 |
Why?
|
| HEK293 Cells | 2 | 2018 | 801 | 0.050 |
Why?
|
| Kelch-Like ECH-Associated Protein 1 | 1 | 2023 | 38 | 0.050 |
Why?
|
| Prognosis | 2 | 2024 | 4886 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2024 | 2026 | 0.050 |
Why?
|
| Survival Rate | 2 | 2019 | 2114 | 0.050 |
Why?
|
| Young Adult | 3 | 2025 | 10103 | 0.050 |
Why?
|
| Data Interpretation, Statistical | 1 | 2023 | 226 | 0.050 |
Why?
|
| Colistin | 1 | 2022 | 32 | 0.050 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2013 | 135 | 0.040 |
Why?
|
| Adiposity | 1 | 2023 | 209 | 0.040 |
Why?
|
| Ciprofloxacin | 1 | 2022 | 66 | 0.040 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2023 | 137 | 0.040 |
Why?
|
| Child | 4 | 2025 | 26341 | 0.040 |
Why?
|
| Pedigree | 1 | 2025 | 1677 | 0.040 |
Why?
|
| Mice | 4 | 2024 | 18301 | 0.040 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase RIbeta Subunit | 1 | 2021 | 2 | 0.040 |
Why?
|
| Zebrafish | 1 | 2024 | 418 | 0.040 |
Why?
|
| Transcription Factors | 2 | 2024 | 2406 | 0.040 |
Why?
|
| Molecular Docking Simulation | 1 | 2021 | 161 | 0.040 |
Why?
|
| Catalytic Domain | 1 | 2021 | 161 | 0.040 |
Why?
|
| Cystathionine | 1 | 2019 | 5 | 0.040 |
Why?
|
| Proteome | 1 | 2021 | 285 | 0.040 |
Why?
|
| Protein Engineering | 1 | 2019 | 61 | 0.040 |
Why?
|
| Drug Discovery | 1 | 2021 | 179 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2022 | 859 | 0.040 |
Why?
|
| Homocysteine | 1 | 2019 | 116 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2024 | 993 | 0.040 |
Why?
|
| Fungal Proteins | 1 | 2019 | 136 | 0.040 |
Why?
|
| Cell Proliferation | 2 | 2017 | 2465 | 0.040 |
Why?
|
| Glucose | 1 | 2023 | 853 | 0.040 |
Why?
|
| Protein Folding | 1 | 2019 | 214 | 0.030 |
Why?
|
| Aged | 3 | 2024 | 21025 | 0.030 |
Why?
|
| Insulin | 1 | 2023 | 1149 | 0.030 |
Why?
|
| DNA Repair | 1 | 2021 | 571 | 0.030 |
Why?
|
| Paraplegia | 1 | 2018 | 84 | 0.030 |
Why?
|
| Pain | 1 | 2021 | 450 | 0.030 |
Why?
|
| Phenylalanine | 1 | 2018 | 130 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2019 | 761 | 0.030 |
Why?
|
| Quantitative Trait Loci | 1 | 2019 | 317 | 0.030 |
Why?
|
| Linear Models | 1 | 2019 | 688 | 0.030 |
Why?
|
| Fructosediphosphates | 1 | 2017 | 3 | 0.030 |
Why?
|
| Allosteric Site | 1 | 2017 | 12 | 0.030 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2018 | 145 | 0.030 |
Why?
|
| Whole Genome Sequencing | 1 | 2019 | 362 | 0.030 |
Why?
|
| Cyclic AMP | 1 | 2018 | 220 | 0.030 |
Why?
|
| Allosteric Regulation | 1 | 2017 | 57 | 0.030 |
Why?
|
| United States | 2 | 2026 | 12072 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2021 | 2395 | 0.030 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2017 | 57 | 0.030 |
Why?
|
| Solutions | 2 | 2007 | 50 | 0.030 |
Why?
|
| Phosphotyrosine | 1 | 2016 | 30 | 0.030 |
Why?
|
| Heat Shock Transcription Factors | 1 | 2016 | 22 | 0.030 |
Why?
|
| Crystallization | 2 | 2007 | 83 | 0.030 |
Why?
|
| Half-Life | 1 | 2016 | 149 | 0.030 |
Why?
|
| Diterpenes | 1 | 2016 | 33 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2017 | 146 | 0.030 |
Why?
|
| Mutant Proteins | 1 | 2016 | 111 | 0.030 |
Why?
|
| Interleukin-17 | 1 | 2016 | 125 | 0.030 |
Why?
|
| Spleen | 1 | 2016 | 258 | 0.030 |
Why?
|
| Early Detection of Cancer | 1 | 2019 | 421 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2014 | 81 | 0.030 |
Why?
|
| CDC2 Protein Kinase | 1 | 2014 | 36 | 0.030 |
Why?
|
| Pyrimidinones | 1 | 2014 | 62 | 0.030 |
Why?
|
| Calcium | 1 | 2019 | 1010 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2017 | 1046 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2014 | 237 | 0.030 |
Why?
|
| Colonic Neoplasms | 1 | 2017 | 262 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2019 | 889 | 0.030 |
Why?
|
| Mitosis | 1 | 2014 | 191 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2015 | 975 | 0.030 |
Why?
|
| Herpesvirus 4, Human | 1 | 2016 | 638 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 2014 | 287 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2016 | 463 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2016 | 500 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2015 | 664 | 0.020 |
Why?
|
| Cricetulus | 1 | 2013 | 90 | 0.020 |
Why?
|
| Feedback | 1 | 2014 | 144 | 0.020 |
Why?
|
| CHO Cells | 1 | 2013 | 152 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2024 | 6797 | 0.020 |
Why?
|
| Base Sequence | 1 | 2017 | 2730 | 0.020 |
Why?
|
| Cricetinae | 1 | 2013 | 362 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2015 | 631 | 0.020 |
Why?
|
| Cellular Senescence | 1 | 2014 | 217 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2019 | 3359 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 1071 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2014 | 349 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2014 | 521 | 0.020 |
Why?
|
| Obesity | 1 | 2023 | 2426 | 0.020 |
Why?
|
| Age Determination by Skeleton | 1 | 2011 | 11 | 0.020 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2011 | 16 | 0.020 |
Why?
|
| Risk Factors | 1 | 2026 | 11074 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2014 | 446 | 0.020 |
Why?
|
| DNA Damage | 1 | 2014 | 511 | 0.020 |
Why?
|
| Homologous Recombination | 1 | 2011 | 97 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 1410 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2011 | 300 | 0.020 |
Why?
|
| INDEL Mutation | 1 | 2011 | 93 | 0.020 |
Why?
|
| Cytokines | 1 | 2016 | 1339 | 0.020 |
Why?
|
| Gene Expression | 1 | 2015 | 1481 | 0.020 |
Why?
|
| Codon, Nonsense | 1 | 2011 | 136 | 0.020 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2011 | 134 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2019 | 3711 | 0.020 |
Why?
|
| Skin Neoplasms | 1 | 2017 | 909 | 0.020 |
Why?
|
| RNA, Transfer | 1 | 2009 | 57 | 0.020 |
Why?
|
| Basal Ganglia | 1 | 2009 | 60 | 0.020 |
Why?
|
| Infant | 1 | 2025 | 13352 | 0.020 |
Why?
|
| Neurologic Examination | 1 | 2009 | 185 | 0.020 |
Why?
|
| Exons | 1 | 2011 | 759 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2011 | 3763 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2024 | 12936 | 0.020 |
Why?
|
| Brain | 2 | 2011 | 3175 | 0.020 |
Why?
|
| Pregnancy | 1 | 2021 | 7512 | 0.020 |
Why?
|
| Transcriptome | 1 | 2015 | 1103 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2011 | 1319 | 0.020 |
Why?
|
| Chemical Phenomena | 1 | 2007 | 46 | 0.020 |
Why?
|
| Scattering, Radiation | 1 | 2007 | 52 | 0.020 |
Why?
|
| Bacillus subtilis | 1 | 2007 | 42 | 0.020 |
Why?
|
| Multienzyme Complexes | 1 | 2007 | 76 | 0.020 |
Why?
|
| Genomics | 1 | 2015 | 1621 | 0.020 |
Why?
|
| Phase Transition | 1 | 2006 | 15 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2009 | 587 | 0.020 |
Why?
|
| Light | 1 | 2007 | 166 | 0.020 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2006 | 61 | 0.010 |
Why?
|
| Static Electricity | 1 | 2006 | 44 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 1447 | 0.010 |
Why?
|
| Biopsy | 1 | 2009 | 1239 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2011 | 1075 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2009 | 981 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2011 | 8635 | 0.010 |
Why?
|